These lab-produced options weren't developed with recreational use in mind. From the nineties, John W. Huffman in addition to a crew of fellow chemists at Clemson University designed many of the first formulas for artificial cannabinoid receptor agonists (SCRAs), a family of substances that imitate the physiological and psychological impacts of can